Edwards Lifesciences to Divest U.S. Perfusion Services For $45 Million to Fresenius Medical Care
Edwards Lifesciences Corporation (NYSE: EW), a global leader in products and technologies to treat advanced cardiovascular disease, today announced that it has […]